MO-PHI: General Concepts in TB Treatment
- Strategies for TB Treatment
- Pharmacological Basis of treatment
- Treatment Phases
- Fixed Dose Combinations [FDC]s
- Advantages of FDCs
- FDCs used in NTEP
- First line anti TB drugs
- Second Line anti TB drugs
- TB Drug Regimen
- DR-TB Treatment Regimens
- TB Treatment Initiation
- Pre-treatment Evaluation of TB patients
- Start Treatment for DSTB patient & DRTB patient
- Follow-up of TB patient
- Add and view prescription
- Adding and viewing Patient Notes
- Assigning Patients to ART and DRTB Centres
- Updating and Viewing patient Health Facility details
- TB Treatment Outcome
- Closing Cases and Assigning Treatment Outcomes
- Long Term Post-treatment follow up of TB patients
- Reinitiating case
- Transfer of TB Patient Ownership
- Transferring a patient
MO-PHI: DS-TB Treatment and Care
MO-PHI: Overview of DR-TB Treatment and care
- DR-TB Centres and Network
- DR-TB Treatment Regimens
- Adverse Drug Reactions(ADRs) to Second Line Treatment
- Manage TB India Application
- Pre-treatment Counselling of DR-TB Patients
- Pre treatment evaluation of a DRTB cases
- Interim Treatment Outcomes of DR-TB Cases
- Final Treatment Outcomes of DR-TB Cases
- Follow-up Monitoring of DR-TB Patients
- Follow up sputum examination for DR-TB
MO-PHI: Isoniazid [H] Mono/Poly DR-TB Regimen
- Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
- EVIDENCE FOR ISONIAZID[H] MONO/POLY DR-TB REGIMEN
- Eligibility Criteria for H Mono/poly DR-TB Regimen
- Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
- Replacement Sequence in the H Mono/Poly DR-TB
- Follow up sputum examination for Isoniazid [H] Mono/Poly DR-TB Regimen
MO-PHI: Treatment Support
MO-PHI: Adherence Management
- TB Treatment Adherence
- Importance of Treatment adherence
- Recording and Monitoring Adherence
- Digital Adherence Monitoring Technologies
- Directly Observed Treatment
- Recording Adherence in Treatment card
- Recording manual doses in Ni-kshay
- Recording missed doses in Ni-kshay
- Recording Adherence using TB Arogya Sathi Application
- Monitoring of Adherence by NTEP Staff
- Monitoring of Adherence by Pateint/TS
- Management of Patients with Treatment Interruptions
- Adherence Register
MO-PHI: ADRs to ATT
- Adverse Drug Reactions
- Types of ADR of TB Treatment
- Management of Adverse Drug Reactions(ADRs) of TB Treatment
- Pharmacovigilance in NTEP
- Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
- Adverse Drug Events: H Mono/Poly DR-TB Regimen
- Management of ADR: Rash, Allergy and Anaphylaxis Reaction
- Management of DR-TB ADR: Gastrointestinal Symptoms [Gastritis and abdominal pain]
- Management of DR-TB ADR: Gastrointestinal Symptoms [Nausea and Vomiting]
- Management of DR-TB ADR: Hepatitis
- Management of DR-TB ADR: Giddiness
- Management of DR-TB ADR: QT Prolongation
- Management of DR-TB ADR: Hematological Abnormalities
- Management of DR-TB ADR: Hypothyroidism
- Management of DR-TB ADR: Arthralgia
- Management of DR-TB ADR: Peripheral Neuropathy
- Management of DR-TB ADR: Psychotic Symptoms
- Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity]
- Management of DR-TB ADR: Vestibular Toxicity
Cover
Cover?